Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1721 News Items found Two Inspiring MSK Employees and Why They Lead Cycle for Survival Teams Monday, June 10, 2024 Read the inspiring story of two MSK employees, Jennifer Brosnan and Santosha Vardhana, and why they lead Cycle For Survival teams to raise money to support research into rare cancers. Why One Family Signed Up for Cycle for Survival To Raise Money for Rare Cancer Research Monday, June 10, 2024 After Joshy was successfully treated for pediatric kidney cancer at MSK Kids, his family signed up for Cycle For Survival to raise money for rare cancers. ‘American Symphony’ Monday, June 10, 2024 Learn about "American Symphony," a documentary featuing a love story, a cancer journey, and a campaign to help save people who need bone marrow donations to fight blood cancer. Ask the Expert The Best Ways to Cope with Active Surveillance Thursday, June 6, 2024 Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment. RNA Biology, Stem Cells, and Cancer: At Work with MSK’s Michael Kharas Wednesday, June 5, 2024 An inside look at the research of MSK's Dr. Michael Kharas, whose work on RNA biology is shedding new light on cancer. Cancer Care at Home: MSK Advances Lead the Field Monday, June 3, 2024 Learn how new clinical trials at MSK are helping make cancer care at home a reality. Important Findings for Treating Rare Solid Tumors Reported at 2024 ASCO Meeting Monday, June 3, 2024 Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology. MSK and NIH Scientists Develop AI Tool to Predict How Cancer Patients Will Respond to Immunotherapy Monday, June 3, 2024 In a proof-of-concept study, researchers at MSK and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells. MSK Researchers Present Advances in Lung Cancer Treatment at 2024 ASCO Meeting Monday, June 3, 2024 Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting. Rectal Cancer Disappears After Experimental Use of Immunotherapy Monday, June 3, 2024 Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer